$AVDL
AVADEL PHARMACEUTICALS PLC Stock $avdl

$avdl Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000101247722000010 Filed on August 09, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue	$0.00	$0.00
YoY Change
Gross Profit	$0.00	$0.00
YoY Change
Gross Profit Margin
Selling, General & Admin	$14.10M	$21.80M	$21.64M
YoY Change	-33.77%	43.69%	96.47%
% of Gross Profit
Research & Development	$2.933M	$4.541M	$6.991M
YoY Change	-33.04%	-32.85%	81.49%
% of Gross Profit
Depreciation & Amortization	$401.0K	$247.0K	$259.0K
YoY Change	103.55%	25.38%	17.73%
% of Gross Profit
Operating Expenses	$17.03M	$26.35M	$28.63M
YoY Change	-33.64%	20.1%	92.59%
Operating Profit	-$16.96M	-$29.94M	-$28.63M
YoY Change	-33.91%	36.47%	93.28%
Interest Expense	-$3.564M	-$3.506M	-$2.017M
YoY Change	84.76%	81.66%	4.51%
% of Operating Profit
Other Income/Expense, Net	$448.0K	$192.0K	-$104.0K
YoY Change
Pretax Income	-$20.08M	-$33.25M	-$30.75M
YoY Change	-25.93%	42.43%	91.55%
Income Tax	$70.00K	$30.19M	-$4.323M
% Of Pretax Income
Net Earnings	-$20.15M	-$63.44M	-$26.42M
YoY Change	-8.44%	224.01%	96.53%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.33	-$1.07	-$0.45
Diluted Earnings Per Share	-$0.33	-$1.07	-$0.45
COMMON SHARES
Basic Shares Outstanding	59.79M shares	59.04M shares	58.82M shares
Diluted Shares Outstanding	60.20M shares	59.04M shares	58.82M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$106.5M	$104.1M	$123.5M
YoY Change	-41.2%	-49.03%	-40.2%
Cash & Equivalents	$60.72M	$54.13M	$60.87M
Short-Term Investments	$45.76M	$49.99M	$62.61M
Other Short-Term Assets	$567.0K	$203.0K	$156.0K
YoY Change	48.43%	-58.74%	4.7%
Inventory
Prepaid Expenses	$3.745M	$3.881M	$5.317M
Receivables	$277.0K	$277.0K	$278.0K
Other Receivables	$2.158M	$17.23M	$31.51M
Total Short-Term Assets	$113.2M	$125.7M	$160.7M
YoY Change	-44.99%	-45.51%	-33.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$896.0K	$252.0K	$268.0K
YoY Change	194.74%	-21.5%	-22.09%
Goodwill	$16.84M	$16.84M	$16.84M
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$11.72M	$11.77M	$39.64M
YoY Change	-69.24%	-62.63%	43.0%
Total Long-Term Assets	$32.54M	$32.23M	$60.39M
YoY Change	-44.16%	-37.9%	19.28%
TOTAL ASSETS
Total Short-Term Assets	$113.2M	$125.7M	$160.7M
Total Long-Term Assets	$32.54M	$32.23M	$60.39M
Total Assets	$145.8M	$157.9M	$221.1M
YoY Change	-44.81%	-44.11%	-24.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.479M	$7.318M	$6.048M
YoY Change	-63.94%	43.04%	114.16%
Accrued Expenses	$7.965M	$9.675M	$9.432M
YoY Change	-8.85%	28.59%	119.5%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$26.30M	$26.24M	$26.18M
YoY Change
Total Short-Term Liabilities	$41.51M	$46.22M	$44.02M
YoY Change	136.03%	183.89%	382.71%
LONG-TERM LIABILITIES
Long-Term Debt	$109.9M	$108.1M	$116.5M
YoY Change	-22.63%	-23.77%	-17.63%
Other Long-Term Liabilities	$5.727M	$5.716M	$3.847M
YoY Change	43.21%	40.51%	-7.05%
Total Long-Term Liabilities	$115.7M	$113.8M	$120.4M
YoY Change	-20.83%	-21.98%	-17.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$41.51M	$46.22M	$44.02M
Total Long-Term Liabilities	$115.7M	$113.8M	$120.4M
Total Liabilities	$158.2M	$161.3M	$165.9M
YoY Change	-4.2%	-1.49%	6.05%
SHAREHOLDERS EQUITY
Retained Earnings	-$557.8M	-$537.6M	-$474.2M
YoY Change	31.1%	33.26%	23.53%
Common Stock	$573.2M	$560.6M	$554.4M
YoY Change	4.77%	2.93%	2.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$12.44M	-$3.332M	$55.23M
YoY Change
Total Liabilities & Shareholders Equity	$145.8M	$157.9M	$221.1M
YoY Change	-44.81%	-44.11%	-24.51%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$20.15M	-$63.44M	-$26.42M
YoY Change	-8.44%	224.01%	96.53%
Depreciation, Depletion And Amortization	$401.0K	$247.0K	$259.0K
YoY Change	103.55%	25.38%	17.73%
Cash From Operating Activities	-$6.803M	-$14.09M	-$34.05M
YoY Change	-67.97%	38.74%	45.41%
INVESTING ACTIVITIES
Capital Expenditures	-$716.0K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$3.240M	$12.05M	$42.25M
YoY Change	-73.65%	-33.51%	276.57%
Cash From Investing Activities	$2.524M	$12.05M	$42.25M
YoY Change	-79.47%	-33.53%	277.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	10.72M	-4.803M	$2.009M
YoY Change	9299.12%	480200.0%	1248.32%
NET CHANGE
Cash From Operating Activities	-6.803M	-14.09M	-$34.05M
Cash From Investing Activities	2.524M	12.05M	$42.25M
Cash From Financing Activities	10.72M	-4.803M	$2.009M
Net Change In Cash	6.436M	-6.845M	$10.17M
YoY Change	-172.89%	-185.91%	-181.0%
FREE CASH FLOW
Cash From Operating Activities	-$6.803M	-$14.09M	-$34.05M
Capital Expenditures	-$716.0K	$0.00	$0.00
Free Cash Flow	-$6.087M	-$14.09M	-$34.05M
YoY Change	-71.34%	38.68%	45.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001012477
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2020	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	AVADEL PHARMACEUTICALS PLC
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	L2
	dei	Entity File Number EntityFileNumber	000-28508
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1341933
	dei	Entity Address Address Line1 EntityAddressAddressLine1	10 Earlsfort Terrace
	dei	Entity Address City Or Town EntityAddressCityOrTown	Dublin 2
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	D02 T380
	dei	Entity Address Country EntityAddressCountry	IE
	dei	Country Region CountryRegion	353
	dei	City Area Code CityAreaCode	1
	dei	Local Phone Number LocalPhoneNumber	901-5201
	dei	Security12b Title Security12bTitle	Ordinary Shares, nominal value $0.01 per share**
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	59793371	shares
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4541000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6762000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11532000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10614000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	21804000	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15174000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	43439000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	26186000	usd
CY2022Q2	us-gaap	Restructuring Charges RestructuringCharges	3592000	usd
CY2021Q2	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2022Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	3506000	usd
	us-gaap	Restructuring Charges RestructuringCharges	3592000	usd
	us-gaap	Restructuring Charges RestructuringCharges	-53000	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	29937000	usd
CY2021Q2	us-gaap	Costs And Expenses CostsAndExpenses	21936000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	58563000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	36747000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-29937000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-21936000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-58563000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-36747000	usd
CY2022Q2	us-gaap	Investment Income Net InvestmentIncomeNet	192000	usd
CY2021Q2	us-gaap	Investment Income Net InvestmentIncomeNet	432000	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	55000	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	1042000	usd
CY2022Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	3506000	usd
CY2021Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	1930000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	5523000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	3859000	usd
CY2022Q2	us-gaap	Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount	0	usd
CY2021Q2	us-gaap	Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount	88000	usd
	us-gaap	Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount	33000	usd
	us-gaap	Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount	166000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-33251000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23346000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-63998000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39398000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30193000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3765000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25870000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6372000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-63444000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-19581000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-89868000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-33026000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.07
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.52
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.07
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.52
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59037000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58488000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58931000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58465000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59037000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58488000	shares
CY2021Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	1930000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58931000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58465000	shares
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-63444000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-19581000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-89868000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-33026000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-657000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	116000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-842000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-602000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	330000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	78000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	133000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-629000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-160000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1546000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-697000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1286000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-44000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2388000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1299000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-64730000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19625000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-92256000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-34325000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54128000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	50708000	usd
CY2022Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	49993000	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	106513000	usd
CY2022Q2	avdl	Research And Development Tax Credit Receivable Current ResearchAndDevelopmentTaxCreditReceivableCurrent	2205000	usd
CY2021Q4	avdl	Research And Development Tax Credit Receivable Current ResearchAndDevelopmentTaxCreditReceivableCurrent	2443000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19387000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	32826000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	125713000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	192490000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	252000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	285000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2180000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2652000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	16836000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	16836000	usd
CY2022Q2	avdl	Research And Development Tax Credit Receivable Non Current ResearchAndDevelopmentTaxCreditReceivableNonCurrent	1187000	usd
CY2021Q4	avdl	Research And Development Tax Credit Receivable Non Current ResearchAndDevelopmentTaxCreditReceivableNonCurrent	1225000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11770000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	33777000	usd
CY2022Q2	us-gaap	Assets Assets	157938000	usd
CY2021Q4	us-gaap	Assets Assets	247265000	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	26241000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	932000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	900000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	7318000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7679000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9675000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7151000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2051000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5270000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	46217000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21000000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	108074000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	142397000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1263000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1707000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5716000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3917000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	161270000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	169021000	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	488000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	488000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	488000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	488000	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	5000	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	5000	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	59038000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59038000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	58620000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	58620000	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	590000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	586000	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	560025000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	549349000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-537624000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-447756000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-26328000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-23940000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-3332000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	78244000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	157938000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	247265000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	78244000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-26424000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1102000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1906000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	0	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	103000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2505000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	55232000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-63444000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1286000	usd
CY2022Q2	avdl	Adjustments To Additional Paid In Capital Adjustments In Fair Value Of Convertible Debt Conversion Feature AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature	5508000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	658000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-3332000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	162266000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-13445000	usd
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1255000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	106000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	0	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	43000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1728000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	136504000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-19581000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-44000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2001000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	118880000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-89868000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-33026000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	506000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	417000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2229000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	625000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	25870000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-6228000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3163000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3729000	usd
	us-gaap	Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount	33000	usd
	us-gaap	Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount	166000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	1239000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	757000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-13305000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3106000	usd
	avdl	Increase Decrease In Research And Development Tax Credit Receivable IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable	-30000	usd
	avdl	Increase Decrease In Research And Development Tax Credit Receivable IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable	-3078000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4457000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	176000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2559000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1199000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	2678000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	1021000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-48135000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-33566000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	26000	usd
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	16500000	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	56501000	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	66213000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	2202000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	53372000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	54299000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	29315000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	4803000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2009000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	149000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2794000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	149000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	50000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-478000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3420000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4580000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	50708000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	71722000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	54128000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67142000	usd
	us-gaap	Interest Paid Net InterestPaidNet	6455000	usd
	us-gaap	Interest Paid Net InterestPaidNet	3234000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-14096000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	7000	usd
CY2022Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	51624000	usd
	avdl	Coupon Interest Expense CouponInterestExpense	3234000	usd
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	295000	usd
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1926000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	49993000	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	106812000	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	948000	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1247000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	106513000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	4000	usd
CY2021Q2	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	41000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	241000	usd
CY2021Q2	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	39000	usd
	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	308000	usd
	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	52000	usd
	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	1031000	usd
	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	107000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2229000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	625000	usd
	avdl	Additional Interest Expense Debt AdditionalInterestExpenseDebt	88000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	11348000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	588000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	3226000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	279000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	14574000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	867000	usd
CY2022Q2	avdl	Adjustments To Additional Paid In Capital Adjustments In Fair Value Of Convertible Debt Conversion Feature AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature	5508000	usd
CY2022Q2	avdl	Debt Instrument Convertible Embedded Conversion Feature Increase Decrease DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease	5508000	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	134000	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	26241000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	108074000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	142397000	usd
CY2022Q2	avdl	Coupon Interest Expense CouponInterestExpense	1589000	usd
CY2021Q2	avdl	Coupon Interest Expense CouponInterestExpense	1617000	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1917000	usd
CY2021Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	313000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	5523000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	3859000	usd
	avdl	Coupon Interest Expense CouponInterestExpense	3206000	usd
CY2022Q2	avdl	Debt Instrument Convertible Embedded Conversion Feature Increase Decrease DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease	5508000	usd
CY2018Q1	avdl	American Depository Shares Conversion Ratio AmericanDepositorySharesConversionRatio	92.6956	rate
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30193000	usd
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.908
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3765000	usd
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.161
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25870000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.404
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6372000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.162
	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	14096000	usd
CY2022Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	15026000	usd
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	29097000	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3881000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3179000	usd
CY2022Q2	avdl	Guarantee Current GuaranteeCurrent	277000	usd
CY2021Q4	avdl	Guarantee Current GuaranteeCurrent	279000	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	203000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	271000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19387000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	32826000	usd
CY2022Q2	avdl	Operating Lease Right Of Use Asset Contract Manufacturing Noncurrent OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent	10600000	usd
CY2021Q4	avdl	Operating Lease Right Of Use Asset Contract Manufacturing Noncurrent OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent	8549000	usd
CY2022Q2	avdl	Guarantee Noncurrent GuaranteeNoncurrent	633000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-33026000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59037000	shares
CY2021Q4	avdl	Guarantee Noncurrent GuaranteeNoncurrent	771000	usd
CY2022Q2	avdl	Other Noncurrent Receivables OtherNoncurrentReceivables	537000	usd
CY2021Q4	avdl	Other Noncurrent Receivables OtherNoncurrentReceivables	329000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	24128000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11770000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	33777000	usd
CY2022Q2	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	3628000	usd
CY2021Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	41000	usd
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3188000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2678000	usd
CY2022Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1592000	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3167000	usd
CY2022Q2	avdl	Accrued Outsource Contract Costs AccruedOutsourceContractCosts	1267000	usd
CY2021Q4	avdl	Accrued Outsource Contract Costs AccruedOutsourceContractCosts	1048000	usd
CY2022Q2	avdl	Accrued Trade Discounts And Rebates AccruedTradeDiscountsAndRebates	0	usd
CY2021Q4	avdl	Accrued Trade Discounts And Rebates AccruedTradeDiscountsAndRebates	217000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9675000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7151000	usd
CY2022Q2	avdl	Accrued Interest Current AccruedInterestCurrent	1757000	usd
CY2021Q4	avdl	Accrued Interest Current AccruedInterestCurrent	4920000	usd
CY2022Q2	avdl	Other Guarantor Obligations Current Carrying Value OtherGuarantorObligationsCurrentCarryingValue	278000	usd
CY2021Q4	avdl	Other Guarantor Obligations Current Carrying Value OtherGuarantorObligationsCurrentCarryingValue	280000	usd
CY2022Q2	avdl	Other Liabilities Miscellaneous Current OtherLiabilitiesMiscellaneousCurrent	16000	usd
CY2021Q4	avdl	Other Liabilities Miscellaneous Current OtherLiabilitiesMiscellaneousCurrent	70000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2051000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5270000	usd
CY2022Q2	avdl	Tax Liabilities And Other Noncurrent Liabilities TaxLiabilitiesAndOtherNoncurrentLiabilities	5081000	usd
CY2021Q4	avdl	Tax Liabilities And Other Noncurrent Liabilities TaxLiabilitiesAndOtherNoncurrentLiabilities	3143000	usd
CY2022Q2	us-gaap	Guaranty Liabilities GuarantyLiabilities	635000	usd
CY2021Q4	us-gaap	Guaranty Liabilities GuarantyLiabilities	774000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5716000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3917000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-63444000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-19581000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-89868000	usd
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58488000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58931000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58465000	shares
CY2022Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2021Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59037000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58488000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58931000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58465000	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.07
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.52
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.07
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.52
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	22455000	shares
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15586000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19042000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15426000	shares
CY2022Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	330000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	78000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	133000	usd
	avdl	Percentage Of Royalty Payable On Net Sales PercentageOfRoyaltyPayableOnNetSales	0.15
CY2022Q2	us-gaap	Guarantee Obligations Current Carrying Value GuaranteeObligationsCurrentCarryingValue	913000	usd
CY2022Q2	avdl	Guarantee Asset Current Carrying Value GuaranteeAssetCurrentCarryingValue	910000	usd
CY2022Q2	us-gaap	Restructuring Charges RestructuringCharges	3592000	usd
CY2021Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	usd
	us-gaap	Restructuring Charges RestructuringCharges	3592000	usd
CY2022Q2	us-gaap	Restructuring Reserve RestructuringReserve	3592000	usd
CY2022Q2	us-gaap	Restructuring Reserve RestructuringReserve	3592000	usd

Files In Submission

Name	View Source	Status
0001012477-22-000010-index-headers.html	Edgar Link	pending
0001012477-22-000010-index.html	Edgar Link	pending
0001012477-22-000010.txt	Edgar Link	pending
0001012477-22-000010-xbrl.zip	Edgar Link	pending
avdl-20220630.htm	Edgar Link	pending
avdl-20220630.xsd	Edgar Link	pending
avdl-20220630_cal.xml	Edgar Link	unprocessable
exhibit311q22022.htm	Edgar Link	pending
exhibit312q22022.htm	Edgar Link	pending
exhibit321q22022.htm	Edgar Link	pending
exhibit322q22022.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
avdl-20220630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
avdl-20220630_def.xml	Edgar Link	unprocessable
avdl-20220630_htm.xml	Edgar Link	completed
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
avdl-20220630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AVDL
AVADEL PHARMACEUTICALS PLC Stock $avdl

2022 Q3 Form 10-Q Financial Statement

#000101247722000010 Filed on August 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVDL AVADEL PHARMACEUTICALS PLC Stock $avdl

2022 Q3 Form 10-Q Financial Statement

#000101247722000010 Filed on August 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVDL
AVADEL PHARMACEUTICALS PLC Stock $avdl